Therapy Areas: Oncology
Ipsen names new EVP and president, Specialty Care International
11 October 2021 -

Biopharmaceutical company Ipsen (Euronext:IPN)(ADR:IPSEY) revealed on Monday the election of Mari Scheiffele as EVP and president of its Specialty Care International and based out of its Boulogne office in France.

Effective 1 November 2021, Scheiffele will serve on the company's executive leadership team, report to its CEO David Loew and work with the international team across its broad reach of markets to launch its transformative innovations around the world.

Most recently, Scheiffele has served as general manager, Novartis Oncology UK & Ireland, where with focus on patient-centricity, evidence-based medicine and partnership and business transformation.

Previously, Scheiffele was a partner at McKinsey & Company in New York and in Switzerland in Pharmaceuticals and Medical Products.



Related Headlines